Race Oncology completes GLP studies for RC220 bisantrene; closer to human trials

By Proactive Investors / June 26, 2024 / www.youtube.com / Article Link

Race Oncology Ltd (ASX:RAC) CEO Dr Daniel Tillett joins Proactive's Jonathan Jackson following the completion of Good ...

Recent News

Several new entrants to TSXV large gold, including producer Asante

November 24, 2025 / www.canadianminingreport.com

Gold stocks down on metal decline, equity market slide

November 24, 2025 / www.canadianminingreport.com

Largest gold producers see strong Q3/25 earnings

November 17, 2025 / www.canadianminingreport.com

Gold stocks jump on gain in metal price

November 17, 2025 / www.canadianminingreport.com

AOCE and WB boost gold targets for 2025 significantly

November 10, 2025 / www.canadianminingreport.com

See all >